Transgenic mice with SCA10 pentanucleotide repeats show motor phenotype and susceptibility to seizure

A toxic RNA gain-of-function model

Misti White, Guangbin Xia, Rui Gao, Maki Wakamiya, Partha Sarkar, Karen McFarland, Tetsuo Ashizawa

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Spinocerebellar ataxia type 10 (SCA10) is an autosomal dominant neurodegenerative disorder manifested by ataxia and seizure. SCA10 is caused by a large expansion of an intronic ATTCT pentanucleotide repeat in the ATXN10 gene. We have recently postulated a toxic RNA-mediated gain of function in the pathogenesis of spinal cerebellar ataxia type 10 (SCA10). The spliced intron-9 RNA containing the expanded AUUCU repeat aggregates in SCA10 cells and sequesters hnRNP K. hnRNP K sequestration triggers the translocation of protein kinase Cδ (PKCδ) to mitochondria, leading to activation of caspase-3 and apoptosis. To confirm the toxic RNA-mediated gain of function, we generated a new transgenic mouse model in which the expanded pentanucleotide repeats are constructed in the 3′-untranslated region (3′UTR) to ensure transcription without translation of the repeat. We constructed an artificial transgene containing the SCA10 (ATTCT) 500 track within the 3′UTR of the LacZ gene driven by the rat prion promoter (PrP) and used this to generate a new transgenic mouse model for SCA10. We then examined these mice for neurological phenotypes and histopathological, molecular, and cellular changes. The transgenic mice showed irregular gait and increased seizure susceptibility at the age of 6 months, resembling the clinical phenotype of SCA10. The cerebral cortex, hippocampus, and pontine nuclei showed neuronal loss. The brains of these animals also showed molecular and cellular changes similar to those previously found in an SCA10 cell model. Expression of the expanded SCA10 AUUCU repeat within the 3′UTR of a gene results in neuronal loss with associated gait abnormalities and increased seizure susceptibility phenotypes, which resemble those seen in SCA10 patients. Moreover, these results bolster the idea that the SCA10 disease mechanism is mediated by a toxic RNA gain-of-function mutation of the expanded AUUCU repeat.

Original languageEnglish (US)
Pages (from-to)706-714
Number of pages9
JournalJournal of Neuroscience Research
Volume90
Issue number3
DOIs
StatePublished - Mar 2012

Fingerprint

Poisons
Microsatellite Repeats
Transgenic Mice
Seizures
RNA
Phenotype
Heterogeneous-Nuclear Ribonucleoprotein K
3' Untranslated Regions
Transgenes
Gait
Spinocerebellar Ataxia 10
Cerebellar Ataxia
Lac Operon
Prions
Ataxia
Caspase 3
Neurodegenerative Diseases
Cerebral Cortex
Introns
Protein Kinase C

Keywords

  • Neurodegenerative disorder
  • Nucleotide repeat
  • RNA gain of function

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience

Cite this

Transgenic mice with SCA10 pentanucleotide repeats show motor phenotype and susceptibility to seizure : A toxic RNA gain-of-function model. / White, Misti; Xia, Guangbin; Gao, Rui; Wakamiya, Maki; Sarkar, Partha; McFarland, Karen; Ashizawa, Tetsuo.

In: Journal of Neuroscience Research, Vol. 90, No. 3, 03.2012, p. 706-714.

Research output: Contribution to journalArticle

White, Misti ; Xia, Guangbin ; Gao, Rui ; Wakamiya, Maki ; Sarkar, Partha ; McFarland, Karen ; Ashizawa, Tetsuo. / Transgenic mice with SCA10 pentanucleotide repeats show motor phenotype and susceptibility to seizure : A toxic RNA gain-of-function model. In: Journal of Neuroscience Research. 2012 ; Vol. 90, No. 3. pp. 706-714.
@article{b460783d36974c70869a10b53cc3595e,
title = "Transgenic mice with SCA10 pentanucleotide repeats show motor phenotype and susceptibility to seizure: A toxic RNA gain-of-function model",
abstract = "Spinocerebellar ataxia type 10 (SCA10) is an autosomal dominant neurodegenerative disorder manifested by ataxia and seizure. SCA10 is caused by a large expansion of an intronic ATTCT pentanucleotide repeat in the ATXN10 gene. We have recently postulated a toxic RNA-mediated gain of function in the pathogenesis of spinal cerebellar ataxia type 10 (SCA10). The spliced intron-9 RNA containing the expanded AUUCU repeat aggregates in SCA10 cells and sequesters hnRNP K. hnRNP K sequestration triggers the translocation of protein kinase Cδ (PKCδ) to mitochondria, leading to activation of caspase-3 and apoptosis. To confirm the toxic RNA-mediated gain of function, we generated a new transgenic mouse model in which the expanded pentanucleotide repeats are constructed in the 3′-untranslated region (3′UTR) to ensure transcription without translation of the repeat. We constructed an artificial transgene containing the SCA10 (ATTCT) 500 track within the 3′UTR of the LacZ gene driven by the rat prion promoter (PrP) and used this to generate a new transgenic mouse model for SCA10. We then examined these mice for neurological phenotypes and histopathological, molecular, and cellular changes. The transgenic mice showed irregular gait and increased seizure susceptibility at the age of 6 months, resembling the clinical phenotype of SCA10. The cerebral cortex, hippocampus, and pontine nuclei showed neuronal loss. The brains of these animals also showed molecular and cellular changes similar to those previously found in an SCA10 cell model. Expression of the expanded SCA10 AUUCU repeat within the 3′UTR of a gene results in neuronal loss with associated gait abnormalities and increased seizure susceptibility phenotypes, which resemble those seen in SCA10 patients. Moreover, these results bolster the idea that the SCA10 disease mechanism is mediated by a toxic RNA gain-of-function mutation of the expanded AUUCU repeat.",
keywords = "Neurodegenerative disorder, Nucleotide repeat, RNA gain of function",
author = "Misti White and Guangbin Xia and Rui Gao and Maki Wakamiya and Partha Sarkar and Karen McFarland and Tetsuo Ashizawa",
year = "2012",
month = "3",
doi = "10.1002/jnr.22786",
language = "English (US)",
volume = "90",
pages = "706--714",
journal = "Journal of Neuroscience Research",
issn = "0360-4012",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Transgenic mice with SCA10 pentanucleotide repeats show motor phenotype and susceptibility to seizure

T2 - A toxic RNA gain-of-function model

AU - White, Misti

AU - Xia, Guangbin

AU - Gao, Rui

AU - Wakamiya, Maki

AU - Sarkar, Partha

AU - McFarland, Karen

AU - Ashizawa, Tetsuo

PY - 2012/3

Y1 - 2012/3

N2 - Spinocerebellar ataxia type 10 (SCA10) is an autosomal dominant neurodegenerative disorder manifested by ataxia and seizure. SCA10 is caused by a large expansion of an intronic ATTCT pentanucleotide repeat in the ATXN10 gene. We have recently postulated a toxic RNA-mediated gain of function in the pathogenesis of spinal cerebellar ataxia type 10 (SCA10). The spliced intron-9 RNA containing the expanded AUUCU repeat aggregates in SCA10 cells and sequesters hnRNP K. hnRNP K sequestration triggers the translocation of protein kinase Cδ (PKCδ) to mitochondria, leading to activation of caspase-3 and apoptosis. To confirm the toxic RNA-mediated gain of function, we generated a new transgenic mouse model in which the expanded pentanucleotide repeats are constructed in the 3′-untranslated region (3′UTR) to ensure transcription without translation of the repeat. We constructed an artificial transgene containing the SCA10 (ATTCT) 500 track within the 3′UTR of the LacZ gene driven by the rat prion promoter (PrP) and used this to generate a new transgenic mouse model for SCA10. We then examined these mice for neurological phenotypes and histopathological, molecular, and cellular changes. The transgenic mice showed irregular gait and increased seizure susceptibility at the age of 6 months, resembling the clinical phenotype of SCA10. The cerebral cortex, hippocampus, and pontine nuclei showed neuronal loss. The brains of these animals also showed molecular and cellular changes similar to those previously found in an SCA10 cell model. Expression of the expanded SCA10 AUUCU repeat within the 3′UTR of a gene results in neuronal loss with associated gait abnormalities and increased seizure susceptibility phenotypes, which resemble those seen in SCA10 patients. Moreover, these results bolster the idea that the SCA10 disease mechanism is mediated by a toxic RNA gain-of-function mutation of the expanded AUUCU repeat.

AB - Spinocerebellar ataxia type 10 (SCA10) is an autosomal dominant neurodegenerative disorder manifested by ataxia and seizure. SCA10 is caused by a large expansion of an intronic ATTCT pentanucleotide repeat in the ATXN10 gene. We have recently postulated a toxic RNA-mediated gain of function in the pathogenesis of spinal cerebellar ataxia type 10 (SCA10). The spliced intron-9 RNA containing the expanded AUUCU repeat aggregates in SCA10 cells and sequesters hnRNP K. hnRNP K sequestration triggers the translocation of protein kinase Cδ (PKCδ) to mitochondria, leading to activation of caspase-3 and apoptosis. To confirm the toxic RNA-mediated gain of function, we generated a new transgenic mouse model in which the expanded pentanucleotide repeats are constructed in the 3′-untranslated region (3′UTR) to ensure transcription without translation of the repeat. We constructed an artificial transgene containing the SCA10 (ATTCT) 500 track within the 3′UTR of the LacZ gene driven by the rat prion promoter (PrP) and used this to generate a new transgenic mouse model for SCA10. We then examined these mice for neurological phenotypes and histopathological, molecular, and cellular changes. The transgenic mice showed irregular gait and increased seizure susceptibility at the age of 6 months, resembling the clinical phenotype of SCA10. The cerebral cortex, hippocampus, and pontine nuclei showed neuronal loss. The brains of these animals also showed molecular and cellular changes similar to those previously found in an SCA10 cell model. Expression of the expanded SCA10 AUUCU repeat within the 3′UTR of a gene results in neuronal loss with associated gait abnormalities and increased seizure susceptibility phenotypes, which resemble those seen in SCA10 patients. Moreover, these results bolster the idea that the SCA10 disease mechanism is mediated by a toxic RNA gain-of-function mutation of the expanded AUUCU repeat.

KW - Neurodegenerative disorder

KW - Nucleotide repeat

KW - RNA gain of function

UR - http://www.scopus.com/inward/record.url?scp=84855877969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855877969&partnerID=8YFLogxK

U2 - 10.1002/jnr.22786

DO - 10.1002/jnr.22786

M3 - Article

VL - 90

SP - 706

EP - 714

JO - Journal of Neuroscience Research

JF - Journal of Neuroscience Research

SN - 0360-4012

IS - 3

ER -